Literature DB >> 8008965

CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation.

I Vouldoukis1, F Issaly, C Fourcade, N Paul-Eugène, M Arock, J P Kolb, O A da Silva, L Monjour, H Poinsot, Y Tselentis.   

Abstract

Leishmania brasiliensis causes cutaneous leishmaniasis (CL) in humans. During this infection, a variety of inflammatory mediators are produced by T cells and monocytes/macrophages. In the present study, we analysed serum IgE levels and their correlation with in situ expression of the low affinity receptor for IgE (Fc epsilon RII/CD23) in patients infected with L. brasiliensis before and following therapy. These analyses were compared to in situ expression of tumour necrosis factor-alpha (TNF alpha), interleukin 3 (IL3), interferon-gamma (IFN gamma) and IL4. Disease-free individuals from the same endemic area sensitized with L. brasiliensis antigens were also included in this work. Our data indicate that during infection, serum levels of IgE and TNF alpha increased and correlated with elevated in situ expression of CD23, IL4 and TNF alpha mRNA. This expression disappeared following successful treatment, but persisted in patients resistant to anti-leishmania therapy. Patients resistant to therapy differed from other cases by a dramatic decrease in their in vivo expression of IFN gamma protein. Analysis of CD23 function in purified human monocytes indicated that this antigen mediates IgE/anti-IgE-dependent TNF alpha production. These data suggest a possible in vivo role of CD23 in acute immune responses in human CL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008965     DOI: 10.1016/s0923-2494(94)80037-5

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  5 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria.

Authors:  P Perlmann; H Perlmann; B W Flyg; M Hagstedt; G Elghazali; S Worku; V Fernandez; A S Rutta; M Troye-Blomberg
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

3.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen.

Authors:  I Vouldoukis; V Riveros-Moreno; B Dugas; F Ouaaz; P Bécherel; P Debré; S Moncada; M D Mossalayi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans.

Authors:  Ana Claudia Maretti-Mira; Jaime Bittner; Manoel Paes Oliveira-Neto; Minghsun Liu; Dezhi Kang; Huiying Li; Claude Pirmez; Noah Craft
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

Review 5.  Biomarkers of Cutaneous Leishmaniasis.

Authors:  Fariborz Bahrami; Ali M Harandi; Sima Rafati
Journal:  Front Cell Infect Microbiol       Date:  2018-06-26       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.